Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionJustInvest LLC
Latest Disclosed Ownership30,004 shares
Latest Disclosed Value $ 1,743,532
JustInvest LLC reports 18.95% increase in ownership of PCVX / Vaxcyte, Inc.

On May 14, 2026 - JustInvest LLC filed a 13F-HR form disclosing ownership of 30,004 shares of Vaxcyte, Inc. (US:PCVX) valued at $1,743,532 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 25,224 shares of Vaxcyte, Inc.. This represents a change in shares of 18.95% during the quarter. The current value of the position is $1,420,989 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VAXCYTE COM 92243G108 30,004 4,780 18.95 1,744 49.87 0.0171
2026-02-13 2025-12-31 13F VAXCYTE COM 92243G108 25,224 9,369 59.09 1,164 103.68 0.0114
2025-10-31 2025-09-30 13F VAXCYTE COM 92243G108 15,855 3,133 24.63 571 38.26 0.0058
2025-07-25 2025-06-30 13F VAXCYTE COM 92243G108 12,722 5,753 82.55 414 57.03 0.0047
2025-05-14 2025-03-31 13F VAXCYTE COM 92243G108 6,969 349 5.27 263 -51.39 0.0039
2025-02-10 2024-12-31 13F VAXCYTE COM 92243G108 6,620 -96 -1.43 542 -29.47 0.0082
2024-11-12 2024-09-30 13F VAXCYTE COM 92243G108 6,716 1,866 38.47 767 109.56 0.0124
2024-08-12 2024-06-30 13F VAXCYTE COM 92243G108 4,850 895 22.63 366 35.56 0.0070
2024-05-09 2024-03-31 13F VAXCYTE COM 92243G108 3,955 648 19.59 270 30.43 0.0058
2024-02-08 2023-12-31 13F VAXCYTE COM 92243G108 3,307 3,307 208 0.0054
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.